Overview of Dr. Vardhana
Dr. Santosha Vardhana is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 6 years. He is one of 503 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 80 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
New York University School of MedicineClass of 2011
Certifications & Licensure
NY State Medical License 2013 - 2026
NJ State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Study of N-acetylcysteine in Patients With COVID-19 Infection Start of enrollment: 2020 May 01
Publications & Presentations
PubMed
- Tackling the next decade of cancer research.Raza Ali, Brittany Jenkins, Wouter Karthaus, Jana Lipkova, Sandra Misale
Trends in Cancer. 2025-03-24 - 1 citationsPhase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2025-03-10 - Host tissue factors predict immune surveillance and therapeutic outcomes in gastric cancer.Miseker Abate, Emily Stroobant, Teng Fei, Ya-Hui Lin, Shoji Shimada
Cancer Immunology Research. 2025-01-09
Abstracts/Posters
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaSantosha Vardhana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Santosha Vardhana, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
Press Mentions
Eleven Scientists Join World-Renowned Faculty at Gerstner Sloan KetteringJuly 15th, 2021- COVID-19 More Deadly with Blood Than Solid Cancer: StudyFebruary 16th, 2021
Shop TalkAugust 25th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
